Literature DB >> 18196971

A reciprocal relationship between Rb and Skp2: implications for restriction point control, signal transduction to the cell cycle and cancer.

Richard K Assoian1, Yuval Yung.   

Abstract

The identification of Skp2 as a direct E2F target has allowed us to document the existence of a positive feedback loop comprised of Rb-E2F, Skp2, p27 and cyclin E-cdk2. We have termed this set of regulatory molecules the Skp2 autoinduction loop. Interference with this loop selectively regulates cell cycle progression through the restriction point. We describe here how the Skp2 autoinduction loop may interact with other regulatory controls on the restriction point, and how the reciprocal relationship between Rb and Skp2 may affect signal transduction to the cell cycle and thinking about the role of Skp2 overexpression in cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18196971     DOI: 10.4161/cc.7.1.5232

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  14 in total

1.  Rapamycin resistance is linked to defective regulation of Skp2.

Authors:  Hana Totary-Jain; Despina Sanoudou; Cula N Dautriche; Hillary Schneller; Lester Zambrana; Andrew R Marks
Journal:  Cancer Res       Date:  2012-02-06       Impact factor: 12.701

2.  Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft.

Authors:  Manjinder Kaur; Balaiya Velmurugan; Alpna Tyagi; Gagan Deep; Suchitra Katiyar; Chapla Agarwal; Rajesh Agarwal
Journal:  Mol Cancer Ther       Date:  2009-07-28       Impact factor: 6.261

3.  Glypican-1 stimulates Skp2 autoinduction loop and G1/S transition in endothelial cells.

Authors:  Dianhua Qiao; Kristy Meyer; Andreas Friedl
Journal:  J Biol Chem       Date:  2011-12-27       Impact factor: 5.157

4.  A signal transduction pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its correlation with progression in human melanoma.

Authors:  Xuan Qu; Liangliang Shen; Yan Zheng; Yang Cui; Zhihui Feng; Feng Liu; Jiankang Liu
Journal:  J Invest Dermatol       Date:  2013-06-21       Impact factor: 8.551

5.  A robust cell cycle control mechanism limits E2F-induced proliferation of terminally differentiated cells in vivo.

Authors:  Laura A Buttitta; Alexia J Katzaroff; Bruce A Edgar
Journal:  J Cell Biol       Date:  2010-06-14       Impact factor: 10.539

6.  Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.

Authors:  Dana-Lynn T Koomoa; Lisette P Yco; Tamas Borsics; Christopher J Wallick; André S Bachmann
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

Review 7.  Targeting prostate cancer based on signal transduction and cell cycle pathways.

Authors:  John T Lee; Brian D Lehmann; David M Terrian; William H Chappell; Franca Stivala; Massimo Libra; Alberto M Martelli; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

8.  Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells.

Authors:  A R Hussain; A S Khan; S O Ahmed; M Ahmed; L C Platanias; K S Al-Kuraya; S Uddin
Journal:  Cell Prolif       Date:  2010-01-14       Impact factor: 6.831

9.  Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.

Authors:  Savvas C Pavlides; Kuang-Tzu Huang; Dylan A Reid; Lily Wu; Stephanie V Blank; Khushbakhat Mittal; Lankai Guo; Eli Rothenberg; Bo Rueda; Timothy Cardozo; Leslie I Gold
Journal:  Endocrinology       Date:  2013-09-13       Impact factor: 4.736

10.  A general G1/S-phase cell-cycle control module in the flowering plant Arabidopsis thaliana.

Authors:  Xin'Ai Zhao; Hirofumi Harashima; Nico Dissmeyer; Stefan Pusch; Annika K Weimer; Jonathan Bramsiepe; Daniel Bouyer; Svenja Rademacher; Moritz K Nowack; Bela Novak; Stefanie Sprunck; Arp Schnittger
Journal:  PLoS Genet       Date:  2012-08-02       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.